Loss of Memo, a novel FGFR regulator, results in reduced lifespan

Barbara Haenzi, Olivier Bonny, Régis Masson, Susanne Lienhard, Julien H. Dey, Makoto Kuro-O, Nancy E. Hynes

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Memo is a widely expressed 33-kDa protein required for heregulin (HRG)-, epidermal growth factor (EGF)-, and fibroblast growth factor (FGF)-induced cell motility. Studies in mouse embryonic fibroblasts, wild-type or knockout for Memo, were performed to further investigate the role of Memo downstream of FGFR. We demonstrated that Memo associates with the FGFR signalosome and is necessary for optimal activation of signaling. To uncover Memo's physiological role, Memo conditional-knockout mice were generated. These animals showed a reduced life span, increased insulin sensitivity, small stature, graying hair, alopecia, kyphosis, loss of subcutaneous fat, and loss of spermatozoa in the epididymis. Memo-knockout mice also have elevated serum levels of active vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D), and calcium compared to control littermates expressing Memo. In summary, the results from in vivo and in vitro models support the hypothesis that Memo is a novel regulator of FGFR signaling with a role in controlling 1,25(OH)2D production and normal calcium homeostasis.

Original languageEnglish (US)
Pages (from-to)327-336
Number of pages10
JournalFASEB Journal
Volume28
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Knockout Mice
Neuregulin-1
Calcium
Kyphosis
Fibroblast Growth Factors
Calcitriol
Epididymis
Subcutaneous Fat
Alopecia
Fibroblasts
Epidermal Growth Factor
Vitamin D
Hair
Cell Movement
Insulin Resistance
Spermatozoa
Animals
Homeostasis
Chemical activation
Fats

Keywords

  • Calcium
  • Insulin sensitivity
  • Kidney
  • Mineral homeostasis
  • Vitamin D

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology
  • Medicine(all)

Cite this

Haenzi, B., Bonny, O., Masson, R., Lienhard, S., Dey, J. H., Kuro-O, M., & Hynes, N. E. (2014). Loss of Memo, a novel FGFR regulator, results in reduced lifespan. FASEB Journal, 28(1), 327-336. https://doi.org/10.1096/fj.13-228320

Loss of Memo, a novel FGFR regulator, results in reduced lifespan. / Haenzi, Barbara; Bonny, Olivier; Masson, Régis; Lienhard, Susanne; Dey, Julien H.; Kuro-O, Makoto; Hynes, Nancy E.

In: FASEB Journal, Vol. 28, No. 1, 2014, p. 327-336.

Research output: Contribution to journalArticle

Haenzi, B, Bonny, O, Masson, R, Lienhard, S, Dey, JH, Kuro-O, M & Hynes, NE 2014, 'Loss of Memo, a novel FGFR regulator, results in reduced lifespan', FASEB Journal, vol. 28, no. 1, pp. 327-336. https://doi.org/10.1096/fj.13-228320
Haenzi B, Bonny O, Masson R, Lienhard S, Dey JH, Kuro-O M et al. Loss of Memo, a novel FGFR regulator, results in reduced lifespan. FASEB Journal. 2014;28(1):327-336. https://doi.org/10.1096/fj.13-228320
Haenzi, Barbara ; Bonny, Olivier ; Masson, Régis ; Lienhard, Susanne ; Dey, Julien H. ; Kuro-O, Makoto ; Hynes, Nancy E. / Loss of Memo, a novel FGFR regulator, results in reduced lifespan. In: FASEB Journal. 2014 ; Vol. 28, No. 1. pp. 327-336.
@article{d601d160adb343a0bed47d5427df4d93,
title = "Loss of Memo, a novel FGFR regulator, results in reduced lifespan",
abstract = "Memo is a widely expressed 33-kDa protein required for heregulin (HRG)-, epidermal growth factor (EGF)-, and fibroblast growth factor (FGF)-induced cell motility. Studies in mouse embryonic fibroblasts, wild-type or knockout for Memo, were performed to further investigate the role of Memo downstream of FGFR. We demonstrated that Memo associates with the FGFR signalosome and is necessary for optimal activation of signaling. To uncover Memo's physiological role, Memo conditional-knockout mice were generated. These animals showed a reduced life span, increased insulin sensitivity, small stature, graying hair, alopecia, kyphosis, loss of subcutaneous fat, and loss of spermatozoa in the epididymis. Memo-knockout mice also have elevated serum levels of active vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D), and calcium compared to control littermates expressing Memo. In summary, the results from in vivo and in vitro models support the hypothesis that Memo is a novel regulator of FGFR signaling with a role in controlling 1,25(OH)2D production and normal calcium homeostasis.",
keywords = "Calcium, Insulin sensitivity, Kidney, Mineral homeostasis, Vitamin D",
author = "Barbara Haenzi and Olivier Bonny and R{\'e}gis Masson and Susanne Lienhard and Dey, {Julien H.} and Makoto Kuro-O and Hynes, {Nancy E.}",
year = "2014",
doi = "10.1096/fj.13-228320",
language = "English (US)",
volume = "28",
pages = "327--336",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "1",

}

TY - JOUR

T1 - Loss of Memo, a novel FGFR regulator, results in reduced lifespan

AU - Haenzi, Barbara

AU - Bonny, Olivier

AU - Masson, Régis

AU - Lienhard, Susanne

AU - Dey, Julien H.

AU - Kuro-O, Makoto

AU - Hynes, Nancy E.

PY - 2014

Y1 - 2014

N2 - Memo is a widely expressed 33-kDa protein required for heregulin (HRG)-, epidermal growth factor (EGF)-, and fibroblast growth factor (FGF)-induced cell motility. Studies in mouse embryonic fibroblasts, wild-type or knockout for Memo, were performed to further investigate the role of Memo downstream of FGFR. We demonstrated that Memo associates with the FGFR signalosome and is necessary for optimal activation of signaling. To uncover Memo's physiological role, Memo conditional-knockout mice were generated. These animals showed a reduced life span, increased insulin sensitivity, small stature, graying hair, alopecia, kyphosis, loss of subcutaneous fat, and loss of spermatozoa in the epididymis. Memo-knockout mice also have elevated serum levels of active vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D), and calcium compared to control littermates expressing Memo. In summary, the results from in vivo and in vitro models support the hypothesis that Memo is a novel regulator of FGFR signaling with a role in controlling 1,25(OH)2D production and normal calcium homeostasis.

AB - Memo is a widely expressed 33-kDa protein required for heregulin (HRG)-, epidermal growth factor (EGF)-, and fibroblast growth factor (FGF)-induced cell motility. Studies in mouse embryonic fibroblasts, wild-type or knockout for Memo, were performed to further investigate the role of Memo downstream of FGFR. We demonstrated that Memo associates with the FGFR signalosome and is necessary for optimal activation of signaling. To uncover Memo's physiological role, Memo conditional-knockout mice were generated. These animals showed a reduced life span, increased insulin sensitivity, small stature, graying hair, alopecia, kyphosis, loss of subcutaneous fat, and loss of spermatozoa in the epididymis. Memo-knockout mice also have elevated serum levels of active vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D), and calcium compared to control littermates expressing Memo. In summary, the results from in vivo and in vitro models support the hypothesis that Memo is a novel regulator of FGFR signaling with a role in controlling 1,25(OH)2D production and normal calcium homeostasis.

KW - Calcium

KW - Insulin sensitivity

KW - Kidney

KW - Mineral homeostasis

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84894517515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894517515&partnerID=8YFLogxK

U2 - 10.1096/fj.13-228320

DO - 10.1096/fj.13-228320

M3 - Article

C2 - 24056085

AN - SCOPUS:84894517515

VL - 28

SP - 327

EP - 336

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 1

ER -